Repeated hormone injections are routinely used to induce advanced stages of oogenesis in freshwater eels, but this approach may result in aberrant germ cell development. To investigate the underlying causes, levels of sex steroids (testosterone, T; estradiol-17β, E2) and ovarian steroidogenic enzyme mRNAs were compared between artificially maturing Japanese eels and wild-caught, spontaneously maturing New Zealand longfin eels. The latter were employed as reference, as wild Japanese eels in advanced stages of oogenesis are near-impossible to catch. Serum T levels in artificially maturing Japanese eel changed with stage in a pattern that was comparable to that in longfin eels. Likewise, ovarian mRNA levels of most steroidogenic enzyme genes were not qualitatively dissimilar between both eel species when taking developmental stage into account. However, aromatase (cyp19a) mRNA levels, together with serum E2 levels, rapidly increased in artificially maturing Japanese eels in mid-late stages of oogenesis (gonadosomatic index, GSI = 13.8%), whereas no such increase was evident in longfin eels (GSI~6.9%). In addition, sex steroid and target gene mRNA levels fluctuated drastically with each hormone injection. We contend that expression of most target genes, possibly even that of cyp19a, during induced oogenesis could be "normal", with the drastic fluctuations due most likely to hormone delivery through repeated injections. The effects of these fluctuations on gamete quality remain unknown and resolving this issue may prove fruitful in the future to further artificial propagation of anguillid eels.
Introduction
In female vertebrates, gonadal development proceeds under gonadotropic hormone (GTH) control, and gonadotropic actions are mediated by sex steroid hormones mainly secreted by somatic follicular cells surrounding the oocytes [1] [2] [3] . A class of sex steroid hormones, estrogens (especially estradiol-17β, E2) are well-known for their role in stimulating the synthesis of yolk protein precursor (vitellogenin) by the liver [4] . Vitellogenin, which is secreted into the bloodstream, is selectively incorporated into the oocytes, greatly contributing to oocyte growth [2, 5] . After completion of oocyte growth, the diploid oocyte will resume the first meiotic division in response to a maturation-inducing steroid [1, 6] , typically the teleost-specific progestin 17α,20β-dihydroxy-4-pregnen-3-one, to give rise to a fertilizable oocyte.
Steroid hormones are produced from cholesterol by a suite of steroidogenic enzymes [1] . Sex steroid profiles and activities of steroidogenic enzymes throughout the natural reproductive cycle have been reported in many female teleosts. Furthermore, during the last 20 or so years, cDNAs encoding steroidogenic enzyme genes have been isolated from several fish species and their steroidogenic abilities evaluated after transient expression in vitro; early studies include those on P450 cholesterol side-chain cleavage (cyp11a) [7, 8] , 3β-hydroxysteroid dehydrogenase (hsd3b) [9, 10] , P450 17α-hydroxylase/C17-20 lyase (cyp17a1) [11, 12] , 17β-hydroxysteroid dehydrogenase type I (hsd17b1 ) [13] , and the ovarian form of P450 aromatase (cyp19a) [14, 15] . More recently, an additional cyp17 cDNA (cyp17a2) that does not display C17-20 lyase activity has been cloned from several fish, including tilapia, Oreochromis niloticus [16] , and eel, Anguilla japonica [17] .
To date, the relationship between mRNA levels of steroidogenic enzymes and steroid hormone levels in blood serum throughout the natural reproductive cycle has been documented in several fish species, including channel catfish Ictalurus punctatus [18] , zebrafish, Danio rerio [19] , rainbow trout, Oncorhynchus mykiss [20] , and European seabass, Dicentrarchus labrax [21] .
Cyp11a, cyp17, and cyp19a mRNA levels largely correlated with E2 levels in catfish and seabass, but less so in rainbow trout; in zebrafish, the relationship between plasma E2 levels and steroidogenic enzyme gene expression is more difficult to expose, given the asynchronous spawning strategy used by these fish-the cyp19a gene expression profile showed a peak in small oocytes (Stage II: 0.14-0.34 mm) [19] seemingly somewhat earlier than that seen in catfish [18] , trout [20] , or seabass [21] . However, steroid hormone levels in blood of female fish are likely to crudely reflect ovarian steroidogenic enzyme gene expression at large during the natural reproductive cycle.
In the last decade, the spawning area of the Japanese eel (A. japonica) was discovered [22] and mature female and male Japanese eels were captured near the West Mariana Ridge [23] . However, very little is known about the spawning ecology of these fish. Besides, freshwater eels never become sexually mature in captivity and hence, artificial induction of oocyte growth and maturation has been attempted using exogenous hormones, such as salmon pituitary homogenates (SPH) containing GTH [24] . In Japanese eel, the titer of steroid hormones and the activities of steroidogenic enzymes do not increase without such exogenous hormone treatment [25] . Indeed, gonadotropin treatment appears to be a prerequisite for the induction of advanced stages of oogenesis in anguillids [26] .
Interestingly, steroidogenesis in artificially maturing female eels appears to proceed differently to that in naturally maturing non-anguillid female fish; for example, weekly injections of GTH rapidly, but temporarily, elevate the levels of several steroid hormones, which decrease a few days later. Thus, levels of circulating steroids are markedly different in artificially maturing eels from those in other female teleosts; moreover, 17α,20β-dihydroxy-4-pregnen-3-one is typically not detectable at the maturational stage [27] . These differences quite likely reflect prolonged exogenous hormone treatment rather than differences in taxa per se [28] . This notion is reinforced by the fact that the survival rates of artificially produced larvae have been typically low [29, 30] and that polyploidy [31] and deformities [32, 33] are widespread among artificially produced larvae, despite advances made in the last 20 years or so [34] . In light of these observations, prolonged exogenous hormone treatment is likely to induce ovarian development that may not closely match the situation in wild conspecifics. Unfortunately, this prediction cannot be tested, as wild conspecifics in vitellogenic or later stages of oogenesis are virtually inaccessible to science.
Wild migratory New Zealand longfin eels, A. dieffenbachii, are more accessible and further advanced in terms of sexual development (up to the midvitellogenic stage, MV) than other temperate anguillids [35, 36] . Therefore, naturally maturing longfin eels may be suitable for assessing whether artificially maturing Japanese eels progress through oogenesis 'normally', or whether development is aberrant. In the present study, we compared the levels of serum steroids and of ovarian steroidogenic enzyme transcript abundance between artificially maturing Japanese eels and naturally maturing longfin eels at pre-and midvitellogenic stages.
Results

Gonadosomatic Indices in Japanese and Longfin Eels
Gonadosomatic indices (GSIs) of Japanese and longfin eels at the previtellogenic (PV) stage were 2.3 ± 0.5% and 0.7 ± 0.3%, respectively. Relative gonad weights in wild longfin eels at the MV stage were much higher, having increased to 6.9 ± 0.3%, a value in between that of artificially maturing Japanese eels in EV (4.7 ± 1.4%) and MV groups (13.8 ± 4%) in the present study ( Figure 1 ).
Serum Steroid Hormone Levels in Japanese and Longfin Eels
Serum T and E2 levels of both eel species at the PV stage were low (ca. 0.5 ng/mL). In wild longfin eels, T levels had approximately doubled upon reaching the MV stage, averaging 1.1 ng/mL (Figure 2a ). In SPH-injected Japanese eels, T levels similarly averaged 1.0-1.1 ng/mL. However, in eels sampled two days after SPH treatment, T levels were notably higher, reaching 2.3 ± 0.8 ng/mL during midvitellogenesis. Similarly, E2 concentrations of MV Japanese eels sampled 2 days after SPH treatment (3.2 ± 1.1 ng/mL) were significantly higher than those sampled just prior to SPH treatment (0.8 ± 0.1 ng/mL), whereas E2 levels in longfin eels were intermediate (1.9 ± 0.02 ng/mL; Figure 2b ). Steroid levels in Ringer-injected controls were similar to those in pretreatment Japanese eels (data not shown).
Isolation of Five Steroidogenic Enzyme cDNA Fragments from Longfin Eel Ovary
All of the 12-18 cDNA clones encoding steroidogenic enzymes of longfin eel showed high homology with the nucleotide (amino acid) sequence of steroidogenic enzymes of Japanese eel: cyp11a: 99.2 (98.8)%, hsd3b: 97.1 (95)%, cyp17a1: 98.4 (98.5)%, hsd17b1: 97.2 (97)%, and cyp19a: 98.8 (99)%.
Expression of Ovarian Steroidogenic Enzymes in Japanese and Longfin Eels
Cyp11a. Ovarian cyp11a mRNA levels reflected relative gonadal size, with values increasing with increasing GSI (Figure 3a ). Interestingly, increases in cyp11a transcript abundance with GSI were approximately linear and showed a very comparable pattern between species; thus, ovarian cyp11a transcript abundance in artificially maturing Japanese eels and naturally maturing longfin eels superficially fitted the same trendline. Of further note was the observation that cyp11a mRNA levels increased upon pituitary homogenate injections, with increases appearing significant in Japanese eels in midvitellogenesis ( Figure 3a ).
Hsd3b. Abundance of hsd3b transcripts showed a modest nonsignificant trend of increasing as oogenesis proceeded. Furthermore, there was no difference in hsd3b mRNA levels between eels sampled just before and two days after pituitary homogenate administration ( Figure 3b ). Cyp17. Changes in cyp17a1 mRNA levels with development showed a comparable pattern to that seen for cyp11a; thus, expression increased with GSI but not dramatically (about two-fold, when comparing previtellogenic and midvitellogenic Japanese eels). The most notable change in ovarian cyp17a1 transcript abundance was seen when comparing midvitellogenic Japanese eels sampled just before and two days after pituitary homogenate treatment (Figure 3c ). In contrast, changes in ovarian cyp17a1 mRNA levels over time in both Japanese and longfin eels did not appear to notably differ.
Hsd17b1. Here too, transcript abundance increased as development progressed in a seemingly linear fashion. Moreover, the expression of hsd17b1 was comparable in ovaries between Japanese and New Zealand eels. A significant effect of pituitary homogenate treatment in midvitellogenic females was evident ( Figure 3d ).
Cyp19a. Cyp19a expression was low during the greater part of development in both species, a dramatic increase occurring in midvitellogenic Japanese eels with an average GSI of nearly 14%. A further increase was evident several days after SPH administration ( Figure 3e ). Hsd17b1. Here too, transcript abundance increased as development progressed in a seemingly linear fashion. Moreover, the expression of hsd17b1 was comparable in ovaries between Japanese and New Zealand eels. A significant effect of pituitary homogenate treatment in midvitellogenic females was evident ( Figure 3d ).
Cyp19a. Cyp19a expression was low during the greater part of development in both species, a dramatic increase occurring in midvitellogenic Japanese eels with an average GSI of nearly 14%. A further increase was evident several days after SPH administration ( Figure 3e ). Hsd17b1. Here too, transcript abundance increased as development progressed in a seemingly linear fashion. Moreover, the expression of hsd17b1 was comparable in ovaries between Japanese and New Zealand eels. A significant effect of pituitary homogenate treatment in midvitellogenic females was evident (Figure 3d ).
Cyp19a. Cyp19a expression was low during the greater part of development in both species, a dramatic increase occurring in midvitellogenic Japanese eels with an average GSI of nearly 14%. A further increase was evident several days after SPH administration (Figure 3e ). 
Discussion
Artificial maturation techniques have been applied successfully for production of eel larvae, but yields have been low-in part reflecting low egg quality-which may be impractical for the production of commercial quantities of seedlings in the future [34] . A poor match between oocyte development in artificially maturing freshwater eels and that in maturing eels in their natural environment has been proposed as the most parsimonious explanation for these observations [25, 37] . To test this idea, we compared steroid biology between artificially and naturally maturing eels as steroids are key mediators of the gonadotropic signals that drive oogenesis. We employed wildcaught vitellogenic longfin eel as our reference against which artificially maturing Japanese eels were compared because Japanese eels in vitellogenesis are essentially not accessible from the wild. Our findings suggest that ovarian steroidogenic physiology is not obviously different between these two groups of eels during the early stages of vitellogenic growth.
Serum levels of T and E2 increased with gonad size in wild-caught longfin eels, yielding values for migrants (1.1 and 1.9 ng/mL, respectively) that were comparable to those reported previously (0.8 and 2.5 ng/mL, respectively) [36] . In artificially maturing Japanese eels in early vitellogenesis, concentrations of T were very similar to those in longfin eels; upon further gonadal growth, T levels increased, but only to a small extent; thus, the mean T level in Japanese eels around the time of SPH injection showed a trend over time that is not unlike that for longfin eel. However, T levels in the latter are likely to be controlled within a tight range, whereas, in artificially maturing Japanese eels, 
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Serum levels of T and E2 increased with gonad size in wild-caught longfin eels, yielding values for migrants (1.1 and 1.9 ng/mL, respectively) that were comparable to those reported previously (0.8 and 2.5 ng/mL, respectively) [36] . In artificially maturing Japanese eels in early vitellogenesis, Fishes 2019, 4, 52 6 of 12 concentrations of T were very similar to those in longfin eels; upon further gonadal growth, T levels increased, but only to a small extent; thus, the mean T level in Japanese eels around the time of SPH injection showed a trend over time that is not unlike that for longfin eel. However, T levels in the latter are likely to be controlled within a tight range, whereas, in artificially maturing Japanese eels, T levels can vary dramatically with the SPH injection schedule. Indeed, in a previous study on artificially maturing Japanese eels, levels of a suite of steroids, including T, varied widely between fish and with time (in days) post-injection [27] , findings that reflect the injection regime [38] . A comparable situation exists for E2, levels of which in Japanese eels could crudely fit the longfin eel trendline, but the former is characterized by drastic variation associated with SPH treatment, increasing rapidly following treatment, then steadily decreasing during the ensuing days [27] .
Do the fluctuations in serum steroid hormone levels affect the quality of the developing germ cell? This interesting question is one that cannot be answered with the information currently available. Effective maturation protocols that yield high-quality gametes may require regulating the levels of key hormones more tightly to maintain an appropriate environment to support oocyte growth. Such approaches have been successfully used for Japanese eels in the form of sustained-release gonadotropin treatments to induce full maturity, using osmotic minipumps [3] and gelatin and cotton-seed water-in-oil-in-water emulsion [39] , respectively. When employing the latter approach, more eggs were spawned than in the 'traditional' hormone-injected group, but the fertility and quality of the resulting eggs were not different. Similarly, the gelatin and oil-seed oil emulsions were considered to perform better than saline-suspended hormone, but details on egg quality were not reported [39] .
The expression patterns of steroidogenic enzymes in the ovaries of both groups of eels largely reflected the serum steroid levels; indeed, average expression of cyp11a, cyp17a1, hsd3b, and hsd17b1 showed steadily increasing trends, comparable between both species, as gonad size increased. Similar to what was seen for serum steroids, there was a notable difference in ovarian steroidogenic enzyme gene expression in Japanese eels when comparing between groups sampled just prior ("low" expression) and those sampled two days after injection with SPH ("high" expression). Moreover, variability between replicates, depicted as error around the mean, tended to be markedly greater in artificially maturing Japanese eels than in naturally maturing longfin eels.
The expression pattern of cyp19a was notably different from that of other steroidogenic enzyme genes evaluated in this study. Thus, ovarian cyp19a mRNA levels were similar between Japanese and longfin eels during early stages of oogenesis, only to rapidly increase by 3-4 fold in Japanese eels as they were stimulated to advance to midvitellogenesis. A rapid increase in expression of ovarian cyp19a during advanced stages of oogenesis in Japanese eels has been reported previously, both on the basis of mRNA levels [40] and on the basis of aromatase activity-based assays (in vitro conversion of androgens into estrogens [40, 41] . These findings prompted Ijiri et al. [41] to query whether artificial maturation of Japanese eels leads to abnormal steroidogenesis and aberrant oocyte development. Other freshwater eel species also display a rapid increase in blood E2 levels toward completion of oocyte growth [37, [42] [43] [44] [45] .
Physiological aberrations during oogenesis in artificially maturing eels seem inevitable, especially when considering the drastic variations in steroid levels, which acutely rise and rapidly fall after each SPH injection. We propose that these acute changes in steroid levels are a reflection of the cyclical presence of injected GTHs which are cleared rapidly from circulation after administration [38] ; these GTHs, in turn, are likely to increase the expression of the gene encoding steroidogenic acute regulatory protein (star), a protein that regulates cholesterol transport for subsequent use in steroidogenesis [46] . Indeed, given the strong regulation of the star gene by tropic stimulation in vertebrates [46] , including the eel [37] , a cyclical SPH-dependent pattern in star expression can be expected to result in the observed rise and fall in levels of steroid substrates. Accordingly, the mismatch between cyp19a mRNA and plasma E2 levels that were seen in Japanese eels sampled just before and those sampled two days post-SPH injection conceivably result from the changes in availability of T rather than that of the abundance of the enzyme aromatase or its transcript. Are the rapid increases in serum E2 at the end of oogenesis themselves truly artefactual and indicative of abnormal steroidogenesis? Reid et al. [37] , focusing on the expression of steroidogenic acute regulatory protein (star) in artificially maturing A. australis, proposed that the elevation in plasma levels of E2 in the migratory nucleus stage may be a 'side effect' of the increase in star expression associated with the pre-ovulatory rise in the maturation-inducing progestin, 17α,20β-dihydroxy-4-pregnen-3-one. As such, the increases in levels of E2 were not considered aberrant and could originate from Cyp19a activity in ovarian follicles that constitute later crops of oocytes [37] , a possible scenario akin that proposed for seabass [21] . The findings from the present study do not rule out one viewpoint or the other. However, the negative effects of E2 on expression of the apoptosis-suppressor gene bcl2 in the ovarian follicle of artificially maturing eel [47] merits further study on estrogen physiology during induced spawning studies of eel. To conclusively settle this issue, ovarian tissue from mature eels from the wild, such as those caught in recent years near the West Mariana Ridge [23, 48, 49] , should be assessed for blood levels of E2 and ovarian expression of cyp19a.
Materials and Methods
Animals and Sampling Design
Sampling of Japanese Eels
Cultivated female Japanese eels (body weight 500-1200 g), feminized by E2 administration, were obtained from Aichi Fisheries Experimental Station and acclimated to seawater prior to experimentation [50] . Before hormone treatment, five eels (initial controls), all in the previtellogenic (PV) stage, were euthanized by spinal transection after anesthesia in 0.1% benzocaine. Blood was collected for steroid hormone analysis by radioimmunoassay (see Section 4.3) and ovarian tissue for microscopical examination (Section 4.2) and gene expression analyses by quantitative PCR (Section 4.5). To quantify gonadal development, the gonadosomatic index (GSI) was calculated as the ratio of ovary weight over total body weight and expressed as a percentage.
The remaining eels (n = 21) were anesthetized on the day that experimentation commenced (Day 0). Fish then received weekly intramuscular injections of either acetone-dried SPH (40 µg/g body weight; n = 18) suspended in eel Ringer [41] to induce gonadal development, or of eel Ringer only (control Japanese eels; n = 3). To provide insights on the rise and fall of measured endpoints during a weekly injection regime, subsets of the eels were anesthetized after 2-4 weeks (early vitellogenic, EV; n = 8) and after 5-7 weeks of treatment with SPH (midvitellogenic; MV; n = 10) or Ringer (PV; n = 3). Blood was sampled by syringe from the caudal vasculature, and ovarian biopsies were obtained as described previously [42] . These eels were killed by anesthetic overdose after 2-4 weeks (EV; n = 8) and after 5-7 weeks of treatment with SPH (MV; n = 10) or Ringer (PV; n = 3); samples from remaining eels were collected two days later. Blood and gonad samples were collected for analysis, as described above. Experiments with eels were performed according to the recommendations of the ethical guidelines of Hokkaido University approved by the Institutional Animal Care and Use Committee of Hokkaido University.
Sampling of Longfin Eels
Female longfin eels (body weight 729-9600 g, n = 25) were caught by fyke net, set overnight, in Lake Ellesmere, New Zealand, during the austral autumn. Fish were transported to the field laboratory (2-4 h) and held in natural spring water (12 • C) until euthanasia by anesthetic overdose for collection of blood and ovarian tissue that same day. The same analyses as for Japanese eels were performed on these samples; in addition, molecular cloning of longfin eel steroidogenic enzyme cDNAs was conducted (Section 4.4). Animals were staged as PV (n = 9) or MV (n = 16) on the basis of histological observations; details on pituitary gonadotropin subunit mRNA levels in these fish were previously published [51] . 
Macroscopical Analyses
Follicles were gently removed from ovarian tissue in Ringer and the mean diameters of the largest size class were determined using a binocular microscope. Follicles were staged on the basis of Kazeto et al. [52] as PV < 200 µm, EV < 200-400 µm, and MV < 400-600 µm in diameter.
Radioimmunoassay
Collected blood was centrifuged at 3000 × g for 10 min at 4 • C and serum stored at -30 • C until use in radioimmunoassay. E2 and T were measured employing the same antisera (Cosmo Bio FKA-235 and FKA-102) and methodology as reported in Matsubara et al. [27] The minimum levels of detectability were 30 pg/mL for both steroids.
Isolation of Partial Steroidogenic Enzyme cDNAs from Longfin Eel Ovary
Ovarian tissues were snap-frozen in liquid nitrogen and kept at -80 • C until use. Total RNA was extracted and first-strand cDNAs synthesized according to Matsubara et al. [28] For molecular cloning of partial cDNAs encoding ovarian steroidogenic enzymes from longfin eels, forward and reverse primers ( Table 1) were designed based on the nucleotide sequences of Japanese eel cyp11a (AY654741), hsd3b (AF063835), cyp17a1 (AY498619), hsd17b1 (AY498620), and cyp19a (AY540622).
Complementary DNA was amplified by polymerase chain reaction using 35 cycles of 94 • C for 30 s, 55 • C for 30 s, and 72 • C for 30 s on an automated thermal cycler (Gene Amp PCR System 9600, PE Applied Biosystems, Foster City, CA, USA). PCR products were subcloned into the pCR2.1 vector (Invitrogen, Carlsbad, CA, USA) and sequenced using an ABI 373 DNA sequencer (Applied Biosystems, Foster City, CA, USA ). The cDNA sequences have been uploaded onto GenBank with the following accession numbers: LC032023 (cyp11a), LC032021 (hsd3b), LC032024 (cyp17a1), LC031820 (hsd17b1), and LC032022 (cyp19a). Table 1 . PCR primer sequences for amplification of partial cDNAs encoding P450 side-chain cleavage (cyp11a), 3β-hydroxysteroid dehydrogenase (hsd3b), P450 17α-hydroxylase/C17-20 lyase (cyp17a1), 17β-hydroxysteroid dehydrogenase Type-I (hsd17b1), and P450 aromatase (cyp19a) from longfin eel ovary.
Gene Primer Sequence
Cyp11a sense 5'-GTTCATCGTATCATGCTCAAC-3' antisense 5'-AGTCCACCTCTCCTATGTTG-3' 
Real-Time Quantitative PCR (qPCR)
Using Primer Express Software ver. 1.0 (Applied Biosystems, Foster City, CA, USA), specific primers and TaqMan molecular probes were designed across regions of the steroidogenic enzyme nucleotide sequences that exactly matched between both eel species. Sequences of primers and probes (Applied Biosystems, Foster City, CA, USA) for qPCR analysis of hsd3b, hsd17b1, and cyp19a (Matsubara et al. [28] ), and β-actin [51] were previously reported. The qPCR probe for cyp11a, yielding an amplicon of 82 bp, was redesigned, as follows: probe 5'(FAM)-CCACTCGATTGGTCCTAAACAAGCAAGTAAT-3'(TAMURA). Primers and probe for cyp17a1, yielding an amplicon of 131 bp, were redesigned, as follows:
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Quantitative PCR analyses were performed as described by Matsubara et al. [28] The linear range of the standard curves fell within 10 1 -10 7 copies and correlation coefficients were more than 0.995 for all curves. The intra-assay coefficient of variation was less than 8% (n = 3 for all assays). Inter-assay coefficients of variation were less than 10% (all assays: n = 3).
Statistical Analysis
Data are presented as means ± SEM. Data on GSI, serum steroid levels, and mRNA levels of ovarian steroidogenic enzymes (normalized over those of β-actin; see Saito et al. [51] ) in artificially maturing Japanese eels and wild-caught longfin eels were analyzed using a one-way anova followed by Fisher's Least Significant Difference post hoc test. Significance was accepted at P < 0.05.
Conclusions
In conclusion, the present study has provided compelling evidence to suggest that early stages of gonadotropin-dependent oocyte growth may not differ dramatically between wild, naturally maturing longfin eels from New Zealand and artificially maturing Japanese eels. The key differences in terms of steroid biology between both groups seem to center around the drastic acute fluctuations in steroid levels in serum and the accompanying expression of steroidogenic enzymes in the ovary of Japanese eels. It remains unclear whether these fluctuations affect germ cell quality, but they underline the need for further refinements of induced spawning protocols in freshwater eels. Funding: This study was supported by grants from the Ministry of Education, Science and Culture, Japan; the Fisheries Agency, Japan; and the Japan Society for the Promotion of Science for Young Scientists and for Research for Future Program (00J07078,05J00244) to H.M.
